Firm News: Oct. 2014

Perry Weitz of Weitz & Luxenberg will co-chair a prestigious Perrin Conferences asbestos-litigation symposium Dec. 2 at the New York Athletic Club in Manhattan. Eight New York trial and appellate court judges along with one special master are slated to speak at Perrin’s 4th annual “Litigating Asbestos Cases in Today’s Environment, Featuring Insights from the…

Mounting evidence that the drug Xarelto increases the risk of brain hemorrhage, hemorrhagic stroke, gastrointestinal bleeding, and other forms of serious bleeding prompted leading national personal injury law firm W&L to today announce it is initiating cases on behalf of patients injured by this prescription medication. Xarelto (rivaroxaban) is a specific type of Factor Xa…

UPDATE: Weitz & Luxenberg is no longer accepting  new clients for this lawsuit. Reports of at least four deaths and nearly 150 injuries from exploding airbags that hurl jagged, razor-sharp pieces of shrapnel at drivers and passengers spurred leading national law firm Weitz & Luxenberg to today announce it is preparing for a class action…

Two keys that earlier this year led to a $9-billion courtroom victory by Weitz & Luxenberg, P.C., against the maker of the diabetes drug Actos, were revealed Monday when National Law Journal named the New York City-based personal injury firm to its debut list of “America’s Elite Trial Lawyers.” Key Number One — a massive investment…